Department of Error

No authors listed

Published Erratum

No authors listed. Lancet. 2017.

. 2017 Jan 21;389(10066):254.

doi: 10.1016/S0140-6736(17)30042-9. Epub 2017 Jan 9.

No abstract available

Erratum for

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
Lublin F, Miller DH, Freedman MS, Cree BAC, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L; INFORMS study investigators. Lublin F, et al. Lancet. 2016 Mar 12;387(10023):1075-1084. doi: 10.1016/S0140-6736(15)01314-8. Epub 2016 Jan 28. Lancet. 2016. PMID: 26827074 Clinical Trial.
Trastuzumab emtansine and cost-based decision making.
The Lancet. The Lancet. Lancet. 2017 Jan 7;389(10064):2. doi: 10.1016/S0140-6736(17)30006-5. Epub 2017 Jan 6. Lancet. 2017. PMID: 28091366 No abstract available.